Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 117

1.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

2.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

3.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

4.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators.

N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114.

5.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
6.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators.

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
7.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif JC, Ponikowski P, Kahan T; ASSOCIATE Study Investigators.

Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.

8.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
10.

[Evaluation of arrhythmia in patients with acute myocardial infarction receiving neoton (phosphocreatine)].

Tomaszewski A, Markiewicz M, Dabrowski P, Baszak J, Jach A, Trojnar R, Wysokiński A.

Wiad Lek. 1994 Aug;47(15-16):570-3. Polish. No abstract available.

PMID:
7716951
11.

[Echocardiographic evaluation of left ventricular function in patients after myocardial infarction treated with enalapril].

Trojnar R, Rymar B, Wysokiński A, Markiewicz M.

Wiad Lek. 1994 Aug;47(15-16):561-5. Polish.

PMID:
7716949
12.

[Effect of physical exercise on aortic blood flow in patients with primary arterial hypertension].

Trojnar R, Rymar B, Wysokiński A, Markiewicz M, Lakomski B.

Wiad Lek. 1992 Aug;45(15-16):575-9. Polish.

PMID:
1488823
13.

[Heart rupture].

Markiewicz M, Rymar B, Baszak J, Trojnar R.

Kardiol Pol. 1992 Jun;36(6):364-8. Review. Polish. No abstract available.

PMID:
1507746
14.

[Effects of verapamil and propranolol on the left-ventricular diastolic function in patients with primary arterial hypertension].

Trojnar R, Rymar B, Wysokiński A, Markiewicz M.

Kardiol Pol. 1991;35(10):233-7. Polish.

PMID:
1762283
15.

[Curves of aortic and mitral flow recorded by Doppler echocardiography in patients with primary hypertension].

Trojnar R, Wysokiński A, Rymar B, Markiewicz M, Lakomski B.

Wiad Lek. 1990 Mar 1-15;43(5-6):169-74. Polish.

PMID:
2368400
16.

[Dynamics of left ventricular contraction in patients with myocardial infarction after hospital rehabilitation, assessed by Doppler echocardiography].

Wysokiński A, Markiewicz M, Trojnar R, Rymar B.

Wiad Lek. 1989 Nov 15-Dec 15;42(22-24):1097-103. Polish.

PMID:
2637546
17.

[Effect of the treatment with propranolol and pindolol on selected hemodynamic parameters in patients with primary arterial hypertension].

Trojnar R, Markiewicz M, Rymar B, Wysokiński A.

Wiad Lek. 1989 Aug 15-Sep 15;42(16-18):929-34. Polish.

PMID:
2701039
18.

[Value of Doppler echocardiography in evaluating pulmonary arterial pressure in patients with mitral valve defect].

Trojnar R, Rymar B, Wysokiński A, Grzywna R, Wójcik J, Markiewicz M, Rumiński W, Kleinrok A.

Wiad Lek. 1989 May 1;42(9):561-6. Polish.

PMID:
2629323
19.

[Value of sustonit in the treatment of patients with stable angina pectoris].

Markiewicz M, Rymar B, Wysokiński A, Trojnar R.

Wiad Lek. 1989 Apr 1;42(7):417-23. Polish.

PMID:
2516931
20.

[Effect of outpatient rehabilitation on echocardiographic image of left-ventricular function in patients after myocardial infarction].

Wysokiński A, Markiewicz M, Trojnar R, Rymar B, Waseńczuk R.

Wiad Lek. 1988 Nov 1;41(21):1415-20. Polish. No abstract available.

PMID:
3250123

Supplemental Content

Loading ...
Support Center